+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Forecast 2024-2030- Product Image
Global Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Forecast 2024-2030- Product Image
Sale

Global Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5592091
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Screening Market size was estimated at USD 4.90 billion in 2023, USD 5.31 billion in 2024, and is expected to grow at a CAGR of 8.74% to reach USD 8.82 billion by 2030.

Blood screening is a crucial aspect of healthcare that involves analyzing and testing blood samples to detect potential health issues, infections, or disorders. It serves as a vital diagnostic and monitoring tool, ensuring the safety of blood transfusions organ transplants, and tracking the prevalence of various diseases in a population. The increasing number of blood donations/transfusions worldwide, the rising prevalence of infectious disorders, and technological advancements in molecular diagnostics increase the need for blood screening. However, high upfront costs associated with implementing new technologies and a lack of awareness about available tools in underdeveloped regions significantly impede the adoption of blood screening.

Additionally, manufacturers focusing on next-generation sequencing (NGS), CRISPR gene-editing techniques, and artificial intelligence (AI) diagnostics applications offer promising avenues for improving testing accuracy, speed, and cost-efficiency. Manufacturers identify novel biomarkers for various diseases and enhance early detection capabilities, leading to better patient outcomes and increased demand for advanced blood screening tests.

Regional Insights

In the Americas, the demand for blood screening tests is increasing due to their advanced healthcare systems, high-quality research institutions, and funding for innovation. The U.S. Food and Drug Administration (FDA) significantly approves new blood screening technologies to ensure safety and efficacy. In Asia Pacific, rapid economic growth, expanding healthcare infrastructure, and a large patient population are prone to infectious diseases due to high population density. China has recently implemented stringent blood safety regulations following past transfusion-related scandals, leading to increased demand for advanced screening technologies.

The European Union (EU) countries have a highly developed healthcare system with strict blood transfusion services regulations. Investments in R&D activities focused on novel diagnostic technologies contribute to Europe's robust blood screening industry. The Middle East & Africa region showcases a diverse landscape with varying levels of healthcare infrastructure development. Many African countries face challenges relating to inadequate infrastructure and resources for ensuring safe transfusions, posing health risks to recipients.

Market Trends by Segment

  • Product: Rising adoption of instruments and consumables for conducting accurate tests
  • Technology: Development of enzyme-linked immunosorbent assay and mass spectrometry technology
  • Application: Significant applications of infectious disease and cancer screening to prevent the spread of infections
  • End-User: Increasing use of blood screening in hospitals and laboratories

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Harbinger Health Raises $140M to Study Blood-Based Cancer Screening Test

Harbinger Health Inc. has secured USD 140 million in funding to support the clinical validation of their upcoming blood-based cancer screening test. The test aims to detect common epigenetic changes that indicate the onset of tumor development, effectively addressing the challenges associated with evolving tumors. The funding from the series B round is expected to be utilized to conduct a comprehensive study involving 10,000 subjects, expand the commercial team, and initiate additional trials targeting high-risk populations. This investment further enables Harbinger Health to advance its groundbreaking screening technology, bringing it closer to its anticipated launch in 2025.

Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch Prostate Screening Blood Test to Men With Prostate Cancer Risk

In its US clinical laboratory, Oxford BioDynamics PLC, a biotechnology company, has successfully launched its EpiSwitch Prostate Screening blood test to detect prostate cancer. This test boasts an impressive accuracy rate of 94%, allowing it to reliably predict the presence or absence of prostate cancer. As a result of this groundbreaking development, the test is now accessible to men undergoing prostate cancer screening in the United States. With its high level of accuracy and availability, this blood test represents a significant advancement in the field of prostate cancer detection.

Walgreens and Freenome to Advance Blood-Based Test Trials For Cancer

Walgreens has partnered with Freenome Holdings, Inc. to advance clinical trials focused on blood-based tests for early cancer detection. In collaboration with technology provider Curebase, Walgreens will initially enroll patients from diverse populations into Freenome's Sanderson Study. The primary objective of this study is to evaluate the efficacy of blood-based early-detection tests for multiple types of cancer and further aims to drive advancements in cancer detection and improve patient outcomes.

Key Company Profiles

The report delves into recent significant developments in the Blood Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Scientific Designs, Inc., Becton, Dickinson And Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux SA, Danaher Corporation, DiaSorin S.p.A., Environmental & Scientific Instruments Co., F. Hoffmann-La Roche AG, GE HealthCare Technologies, Inc., GFE, Grifols, S.A., Immucor, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc, Omega Laboratories, Inc., OraSure Technologies, Inc., Ortho Clinical Diagnostics, Inc., PerkinElmer, Inc., PixCell Medical Technologies Ltd., Premier Biotech, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.

This research report offers invaluable insights into various crucial aspects of the Blood Screening Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for donated blood and rising number of blood donations
5.1.1.2. Rising prevalence of infectious diseases and the emergence of newer pathogens
5.1.1.3. Increase in affordability and adoption of nucleic acid test for blood screening
5.1.2. Restraints
5.1.2.1. High price for blood screening diagnostics
5.1.3. Opportunities
5.1.3.1. Technological Advancements in blood screening devices
5.1.3.2. Improved POC diagnostics for blood screening
5.1.4. Challenges
5.1.4.1. Lack of legislation, regulations, and policies on blood screening
5.2. Market Segmentation Analysis
5.2.1. Product: Rising adoption of instruments and consumables for conducting accurate tests
5.2.2. Technology: Development of enzyme-linked immunosorbent assay and mass spectrometry technology
5.2.3. Application: Significant applications of infectious disease and cancer screening to prevent the spread of infections
5.2.4. End-User: Increasing use of blood screening in hospitals and laboratories
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Blood Screening Market, by Product & Service
6.1. Introduction
6.2. Instruments
6.3. Outright Purchase
6.4. Reagents & Kits
7. Blood Screening Market, by Technology
7.1. Introduction
7.2. ELISA
7.3. NAT
7.4. NGS
7.5. Rapid Tests
7.6. Western Blot Assays
8. Blood Screening Market, by End-User
8.1. Introduction
8.2. Blood Banks
8.3. Hospitals
9. Americas Blood Screening Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Blood Screening Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Blood Screening Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Harbinger Health Raises $140M to Study Blood-Based Cancer Screening Test
12.3.2. Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch Prostate Screening Blood Test to Men With Prostate Cancer Risk
12.3.3. Walgreens and Freenome to Advance Blood-Based Test Trials For Cancer
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. BLOOD SCREENING MARKET RESEARCH PROCESS
FIGURE 2. BLOOD SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BLOOD SCREENING MARKET DYNAMICS
FIGURE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BLOOD SCREENING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 107. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 108. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 109. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 119. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 120. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 121. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 122. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 123. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 124. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 125. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 128. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 129. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 130. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 131. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 132. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 133. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 134. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 135. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 136. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 137. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 138. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 139. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 140. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 141. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 144. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 145. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 146. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 147. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 148. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 149. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 150. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 151. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 152. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 153. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 154. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 155. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 156. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 157. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 160. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 161. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 162. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 163. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 164. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 165. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 166. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 167. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 168. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 169. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 170. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 171. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 172. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 173. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 176. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 178. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 180. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 182. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 184. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 186. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 188. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 190. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 194. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 195. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 196. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 197. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 198. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 199. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 200. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 201. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 202. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 203. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 204. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 205. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 206. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 207. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 208. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 209. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 212. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 213. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 214. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 215. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 216. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 217. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 218. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 219. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 220. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 221. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 222. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 223. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 224. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 225. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 228. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 229. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 230. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 231. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 232. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 233. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 234. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 235. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 238. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 239. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 240. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 241. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 244. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 245. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 246. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 247. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 248. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 249. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 250. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 251. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 252. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 253. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 254. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 255. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 256. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 257. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 260. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 261. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 262. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 263. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 264. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 265. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 266. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 267. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 268. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 269. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 270. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 271. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 272. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 273. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 276. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 277. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 278. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 279. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 280. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 281. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 282. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 283. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 284. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 285. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 286. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 287. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 288. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 289. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 290. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 291. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 292. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 293. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 294. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 295. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 296. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 297. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 298. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 299. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 300. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 301. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 302. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 303. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 304. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 305. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 306. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 307. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 308. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 309. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 310. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 311. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 312. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 313. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 314. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 315. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 316. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 317. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 318. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 319. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 320. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 321. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 324. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 325. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 326. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 327. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 328. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 329. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 330. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 331. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 332. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 333. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 334. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 335. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 336. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 337. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 340. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 341. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 342. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 343. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 344. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 345. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
TABLE 346. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
TABLE 347. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 348. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 349. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
TABLE 350. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
TABLE 351. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
TABLE 352. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
TABLE 353. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 354. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 355. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 356. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 357. THAILAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (US

Companies Mentioned

  • Abbott Laboratories
  • Alfa Scientific Designs, Inc.
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Environmental & Scientific Instruments Co.
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies, Inc.
  • GFE
  • Grifols, S.A.
  • Immucor, Inc.
  • Laboratory Corporation of America Holdings
  • Lifeloc Technologies, Inc
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • PerkinElmer, Inc.
  • PixCell Medical Technologies Ltd.
  • Premier Biotech, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.31 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.82 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028 - Product Image

Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028

  • Report
  • 253 Pages
  • Global
From
Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA & EIA, NGS, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Blood Screening Market Size, Share & Trends Analysis Report By Technology (NAT, ELISA, CLIA & EIA, NGS, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 90 Pages
  • Global
From
Blood Screening - Global Strategic Business Report - Product Image

Blood Screening - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Blood Screening Global Market Report 2024 - Product Image

Blood Screening Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Blood Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Blood Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.